These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28414135)

  • 1. Gastrointestinal behavior of itraconazole in humans - Part 1: Supersaturation from a solid dispersion and a cyclodextrin-based solution.
    Brouwers J; Geboers S; Mols R; Tack J; Augustijns P
    Int J Pharm; 2017 Jun; 525(1):211-217. PubMed ID: 28414135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal behavior of itraconazole in humans - Part 2: The effect of intraluminal dilution on the performance of a cyclodextrin-based solution.
    Berben P; Mols R; Brouwers J; Tack J; Augustijns P
    Int J Pharm; 2017 Jun; 526(1-2):235-243. PubMed ID: 28450167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linking the concentrations of itraconazole and 2-hydroxypropyl-β-cyclodextrin in human intestinal fluids after oral intake of Sporanox
    Berben P; Stappaerts J; Vink MJA; Domínguez-Vega E; Somsen GW; Brouwers J; Augustijns P
    Eur J Pharm Biopharm; 2018 Nov; 132():231-236. PubMed ID: 29959034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro evaluation of the impact of gastrointestinal transfer on luminal performance of commercially available products of posaconazole and itraconazole using BioGIT.
    Kourentas A; Vertzoni M; Symillides M; Hens B; Brouwers J; Augustijns P; Reppas C
    Int J Pharm; 2016 Dec; 515(1-2):352-358. PubMed ID: 27732895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal dissolution, supersaturation and precipitation of the weak base indinavir in healthy volunteers.
    Rubbens J; Brouwers J; Tack J; Augustijns P
    Eur J Pharm Biopharm; 2016 Dec; 109():122-129. PubMed ID: 27693678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. When Interactions Between Bile Salts and Cyclodextrin Cause a Negative Food Effect: Dynamic Dissolution/Permeation Studies with Itraconazole (Sporanox®) and Biomimetic Media.
    Cuoco A; Eriksen JB; Luppi B; Brandl M; Bauer-Brandl A
    J Pharm Sci; 2023 May; 112(5):1372-1378. PubMed ID: 36539063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Displacement of itraconazole from cyclodextrin complexes in biorelevant media: In vitro evaluation of supersaturation and precipitation behavior.
    Stappaerts J; Augustijns P
    Int J Pharm; 2016 Sep; 511(1):680-687. PubMed ID: 27473276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the processes limiting oral drug absorption when amorphous solid dispersions are administered after a high-calorie, high-fat meal: Sporanox® pellets.
    Dietrich S; Dimoula M; Argyropoulos T; Ceulemans J; Goumas K; Vertzoni M; Reppas C
    Eur J Pharm Sci; 2024 Aug; 199():106798. PubMed ID: 38740075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ordered mesoporous silica induces pH-independent supersaturation of the basic low solubility compound itraconazole resulting in enhanced transepithelial transport.
    Mellaerts R; Mols R; Kayaert P; Annaert P; Van Humbeeck J; Van den Mooter G; Martens JA; Augustijns P
    Int J Pharm; 2008 Jun; 357(1-2):169-79. PubMed ID: 18325700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclodextrin-water soluble polymer ternary complexes enhance the solubility and dissolution behaviour of poorly soluble drugs. Case example: itraconazole.
    Taupitz T; Dressman JB; Buchanan CM; Klein S
    Eur J Pharm Biopharm; 2013 Apr; 83(3):378-87. PubMed ID: 23201048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal and Systemic Monitoring of Posaconazole in Humans After Fasted and Fed State Administration of a Solid Dispersion.
    Hens B; Corsetti M; Brouwers J; Augustijns P
    J Pharm Sci; 2016 Sep; 105(9):2904-2912. PubMed ID: 27178739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioavailability enhancement of itraconazole-based solid dispersions produced by hot melt extrusion in the framework of the Three Rs rule.
    Thiry J; Kok MG; Collard L; Frère A; Krier F; Fillet M; Evrard B
    Eur J Pharm Sci; 2017 Mar; 99():1-8. PubMed ID: 27951411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of itraconazole after intravenous and oral dosing of itraconazole-cyclodextrin formulations.
    Buchanan CM; Buchanan NL; Edgar KJ; Klein S; Little JL; Ramsey MG; Ruble KM; Wacher VJ; Wempe MF
    J Pharm Sci; 2007 Nov; 96(11):3100-16. PubMed ID: 17712849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Dynamic Intestinal Absorption Model (Diamod®), an
    Moens F; Vandevijver G; De Blaiser A; Larsson A; Spreafico F; Augustijns P; Marzorati M
    Int J Pharm X; 2023 Dec; 5():100177. PubMed ID: 37396621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Evaluation of In Vitro Drug Dissolution of Commercially Available Oral Dosage Forms for Itraconazole in Gastrointestinal Simulator With Biorelevant Media.
    Matsui K; Tsume Y; Amidon GE; Amidon GL
    J Pharm Sci; 2016 Sep; 105(9):2804-2814. PubMed ID: 27020985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of surfactants, gastric emptying, and dosage form on supersaturation of dipyridamole in an in vitro model simulating the stomach and duodenum.
    Mitra A; Fadda HM
    Mol Pharm; 2014 Aug; 11(8):2835-44. PubMed ID: 25025699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric and Duodenal Diclofenac Concentrations in Healthy Volunteers after Intake of the FDA Standard Meal: In Vivo Observations and in Vitro Explorations.
    Rubbens J; Brouwers J; Tack J; Augustijns P
    Mol Pharm; 2019 Feb; 16(2):573-582. PubMed ID: 30571131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism for enhanced absorption of a solid dispersion formulation of LY2300559 using the artificial stomach duodenum model.
    Polster CS; Wu SJ; Gueorguieva I; Sperry DC
    Mol Pharm; 2015 Apr; 12(4):1131-40. PubMed ID: 25723790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Itraconazole in cyclodextrin solution.
    Stevens DA
    Pharmacotherapy; 1999 May; 19(5):603-11. PubMed ID: 10331823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modified release itraconazole amorphous solid dispersion to treat Aspergillus fumigatus: importance of the animal model selection.
    Maincent JP; Najvar LK; Kirkpatrick WR; Huang S; Patterson TF; Wiederhold NP; Peters JI; Williams RO
    Drug Dev Ind Pharm; 2017 Feb; 43(2):264-274. PubMed ID: 27645428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.